TrialAIDS and behavior2020

Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077.

Elizabeth E Tolley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.